(Q73120756)
Statements
Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: results of a multicenter phase II trial (English)
A G Maier
B Kersting-Sommerhoff
J W Reeders
W Judmaier
W Schima
A A Annweiler
M Meusel